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Introduction {#sec001}
============

The incidence of thyroid cancer has generally been increasing during recent decades, although the mortality rate has steadily declined \[[@pone.0218171.ref001]\]. For example, during 2008--2012, most countries had age-standardized mortality rates of 0.20--0.40/100,000 men and 0.20--0.60/100,000 women, with steady increases among both sexes in the incidence of thyroid cancer (mainly papillary carcinoma) \[[@pone.0218171.ref001]\]. Differentiated thyroid carcinomas include papillary and follicular thyroid carcinomas \[[@pone.0218171.ref002]\], which are among the most curable of all cancers. However, some patients have a high risk of recurrence or even death from papillary and follicular thyroid carcinomas \[[@pone.0218171.ref003]\], with specific clinicopathological features being associated with progression and a dire prognosis even after extensive surgery, radioactive iodine (RAI) ablation therapy, and thyroid-stimulating hormone suppression \[[@pone.0218171.ref004]\]. Thus, well-established clinicopathological indicators must be used to predict patient prognosis and select treatment for differentiated thyroid carcinoma.

Previous research has indicated that appropriate treatment for thyroid cancer should be selected based on the precise TNM stage \[[@pone.0218171.ref004]--[@pone.0218171.ref006]\]. In this context, minimal extrathyroidal extension (ETE) is defined as tumor cells extending to the sternothyroid muscle or perithyroidal soft tissue \[[@pone.0218171.ref007]\]. Furthermore, there is significant debate regarding whether ETE should be incorporated into the T status for differentiated thyroid cancer, especially as the definitions of thyroid cancer T status were changed in 2002 for the AJCC and UICC systems \[[@pone.0218171.ref008], [@pone.0218171.ref009]\]. The fifth edition of the UICC system defined T3 disease as a \>4-cm tumor without any ETE and T4 disease as any tumor with ETE. In contrast, the sixth edition of the UICC system defined T3 disease as a tumor with a greatest dimension of \>4 cm or any tumor with minimal ETE, while T4a disease was defined as tumors extending beyond the thyroid capsule and with invasion of the subcutaneous soft tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve \[[@pone.0218171.ref010]\]. The eighth edition of the AJCC system was published in 2018 and defines T3 disease as including gross ETE, while the seventh edition defined T4 disease as including gross ETE \[[@pone.0218171.ref011]--[@pone.0218171.ref013]\]. Interestingly, while gross ETE plays an increasingly significant role in the AJCC system, minimal ETE was removed from the definition of T3 disease in the eighth edition \[[@pone.0218171.ref011]\]. Thus, there remains controversy regarding whether the magnitude of ETE (i.e., minimal vs. gross) should be considered in assigning a precise TNM stage to patients with thyroid cancer, and further studies are needed to determine the impact of ignoring minimal ETE and only considering gross ETE when assigning a T status. The present study evaluated Surveillance, Epidemiology, and End Results (SEER) data to determine whether the magnitude of ETE influenced the ability to predict cancer-specific survival (CSS) and overall survival (OS) among patients with differentiated thyroid cancer.

Materials and methods {#sec002}
=====================

This study's retrospective protocol was approved by Zhongnan Hospital and Union hospital's ethical review board and complied with the ethical standards of the Declaration of Helsinki, as well as the relevant national and international guidelines. The study cohort was comprised of 107,114 patients with differentiated thyroid cancer from the SEER database (2004--2013). Among these patients, the extent of tumor extension was classified as confinement to the thyroid parenchyma (80.5%), minimal ETE (6.0%), or gross ETE (10.2%). A total of 3,529 patients were excluded based on missing or unknown data regarding tumor extension.

The patients' demographic parameters were defined as sex (male and female), race (white, black, and other or unknown), and age at diagnosis (≤55 years or \>55 years). Lymph node and distant metastases were classified as present or absent. Treatment characteristics were defined as surgery type (none, lobectomy, subtotal or near-total thyroidectomy, and total thyroidectomy), and radiation therapy (none, radiation beam or radioactive implants, and radioisotopes or radiation beam with isotopes or implants).

The patients' follow-up data were evaluated to calculate the rates of CSS and OS, as well as the mortality rates per 1,000 person-years. Univariate and multivariate Cox regression analyses were performed to examine whether CSS and OS were associated with age, sex, race, histological type, TNM stage, extension status, radiation treatment, or surgery type. Survival curves were generated using the Kaplan-Meier method and analyzed using the log-rank test. To minimize selection bias, propensity-score matching was performed for all relevant factors. Among the whole cohort, the propensity scores were calculated using a multivariate probit regression model that included three sets of relevant risk factors. The first set included age, sex, and race. The second set included the factors from the first set plus TNM stage and multifocality. The third set included the factors from the second set plus surgery type and radiation treatment. Matching was performed using a 1:1 matching protocol with a caliper of 0.1 standard deviations for the probit values. Statistical analyses were performed using SPSS software (version 23.0), StataSE software, and GraphPad Prism software (version 6). Differences were considered statistically significant at P-values of \<0.05.

Results {#sec003}
=======

Demographic and clinicopathological characteristics {#sec004}
---------------------------------------------------

The patients' mean ages and follow-up durations according to the magnitude of ETE are shown in [Table 1](#pone.0218171.t001){ref-type="table"}. Patients with minimal ETE were clearly older than patients with gross ETE. However, there were no significantly differences in the histological types between patients with minimal ETE and gross ETE.

10.1371/journal.pone.0218171.t001

###### Characteristics for patients with different extent of tumor extension.

![](pone.0218171.t001){#pone.0218171.t001g}

  ------------------------------------------------------------------------------------------------------------------------------------------
  Covariate            level             Extent of tumor extension                                                                 
  -------------------- ----------------- --------------------------- ------- -------------- ------ --------- -------------- ------ ---------
  Age at diagnosis                       49.99±16.03                         49.45±15.24           \<0.001   54.18±17.65           \<0.001

  Year of diagnosis    2004--2008        2365                        37      36173          41.9   \<0.001   5386           49.3   \<0.001

  2009--2013           4030              63                          50093   58.1           5538   50.7                            

  Sex                  Female            4621                        72.3    66955          77.6   \<0.001   7388           67.6   \<0.001

  Male                 1774              27.7                        19311   22.4           3536   32.4                            

  Race                 White             5132                        81.2    70750          83.1   \<0.001   8822           81.3   \<0.001

  Black                242               3.8                         6049    7.1            560    5.2                             

  Other                948               15                          8376    9.8            1466   13.5                            

  Histological Types   Papillary         5903                        96.8    76381          93.7   \<0.001   9014           96.3   0.068

  Follicular           193               3.2                         5157    6.3            348    3.7                             

  T stage              T1                18                          0.3     58892          70.2   \<0.001   28             0.3    \<0.001

  T2                   4                 0.1                         17490   20.9           1      0                               

  T3                   6321              98.9                        7223    8.6            6248   57.3                            

  T4                   48                0.8                         266     0.3            4625   42.4                            

  N-Stage              N0                3179                        50.3    71590          84.3   \<0.001   4576           43.4   \<0.001

  N1                   3135              49.7                        13289   15.7           5971   56.6                            

  M-Stage              M0                6104                        97.4    84418          99.2   \<0.001   9495           89.4   \<0.001

  M1                   162               2.6                         716     0.8            1131   10.6                            

  Multifocality        Yes               2914                        47.1    53657          63.4   \<0.001   5103           49.5   0.003

  No                   3275              52.9                        30978   36.6           5211   50.5                            

  Radiation            None or refused   1697                        27.4    47001          55.7   \<0.001   3133           29.3   \<0.001

  Radiation Beam\      207               3.3                         1355    1.6            1161   10.9                            
  or Rdioactive\                                                                                                                   
  implants                                                                                                                         

  Radioisotopes\       4281              69.2                        36032   42.7           6381   59.8                            
  or Radiation\                                                                                                                    
  beam plus\                                                                                                                       
  isotopes or\                                                                                                                     
  implants                                                                                                                         

  Surgery              Lobectomy         314                         5       13852          16.6   \<0.001   661            6.6    \<0.001

  Subtotal or\         142               2.3                         3376    4.1            366    3.7                             
  near-total\                                                                                                                      
  thyroidectomy                                                                                                                    

  Total\               5815              92.7                        66095   79.3           8957   89.7                            
  thyroidectomy                                                                                                                    

  Survival\                              45.03±32.755                        49.71±33.858          \<0.001   47.21±35.073          \<0.001
  months (month)                                                                                                                   

  CSS                  Alive             6267                        98      85713          99.4   \<0.001   9448           86.5   \<0.001

  Death                128               2                           553     0.6            1476   13.5                            

  OS                   Alive             6065                        94.8    82277          95.4   0.05      8627           79     \<0.001

  Death                330               5.2                         3989    4.6            2297   21                              
  ------------------------------------------------------------------------------------------------------------------------------------------

Confinement:confinement to the thyroid parenchyma; Minimal ETE: minimal extrathyroidal extension;Gross ETE: gross extrathyroidal extension

Cancer-specific and all-cause mortality rates {#sec005}
---------------------------------------------

The cancer-specific and all-cause mortality rates were significantly different in the two-group and three-group comparisons ([Table 2](#pone.0218171.t002){ref-type="table"}). During the follow-up period, cancer-specific deaths were detected for 535 patients in the thyroid confinement group, 128 patients in the minimal ETE group, and 1,476 patients in the gross ETE group. The cancer-specific mortality rates per 1,000 person-years were 1.407 for the confinement group (95% confidence interval \[CI\]: 1.288--1.536), 5.133 for the minimal ETE group (95% CI: 4.301--6.124), and 29.735 for the gross ETE group (95% CI: 28.147--31.412) (Tables [2](#pone.0218171.t002){ref-type="table"} and [3](#pone.0218171.t003){ref-type="table"}). During the follow-up period, all-cause deaths were detected for 3,989 patients in the thyroid confinement group, 330 patients in the minimal ETE group, and 2,297 patients in the gross ETE group. The all-cause mortality rates per 1,000 person-years were 9.9 for the confinement group (95% CI: 9.612--10.269), 13.4 for the minimal ETE group (95% CI: 12.046--14.987), and 47.0 for the gross ETE group (95% CI: 44.950--49.052) (Tables [2](#pone.0218171.t002){ref-type="table"} and [3](#pone.0218171.t003){ref-type="table"}).

10.1371/journal.pone.0218171.t002

###### Cancer-specific mortality and all-cause mortality according to different extent of tumor extension.

![](pone.0218171.t002){#pone.0218171.t002g}

  Classification            Cancer-Specific Mortality   All-cause Mortality                                                                                           
  ------------------------- --------------------------- --------------------- -------- -------- -------- --------- --------- ------ ------- ------- ------- --------- ---------
  Ⅰ                         Confinement                 553                   0.6      ref                         \<0.001   3989   4.6     ref                       \<0.001
  Minimal ETE               128                         2                     3.285    2.71     3.982    \<0.001   330       5.2    1.283   1.146   1.437   \<0.001   
  Gross ETE                 1476                        13.5                  22.077   20.016   24.35    \<0.001   2297      21     5.069   4.812   5.34    \<0.001   
  Ⅱ                         Confinement + Minimal ETE   681                   0.7      ref                                   4319   4.6     ref                       
  Gross ETE                 1476                        13.5                  19.173   17.506   21       \<0.001   2297      21     4.979   4.73    5.241   \<0.001   
  Ⅲ                         Confinement                 553                   0.6      ref                                   3989   4.6     ref                       
  Minimal ETE + Gross ETE   1604                        9.2                   15.16    13.759   16.702   \<0.001   2627      15     3.701   3.521   3.891   \<0.001   

Confinement:confinement to the thyroid parenchyma; Minimal ETE: minimal extrathyroidal extension;Gross ETE: gross extrathyroidal extension

10.1371/journal.pone.0218171.t003

###### Hazard ratios of different extent of tumor extension for the cancer specific deaths and all cause deaths of differentiated thyroid cancer.

![](pone.0218171.t003){#pone.0218171.t003g}

  Extension     Cancer-Specific Mortality   \%      Cancer-Specific Mortality   95%CI            All-cause Mortality   \%      All-cause Mortality   95%CI
  ------------- --------------------------- ------- --------------------------- ---------------- --------------------- ------- --------------------- ----------------
  Confinement   553                         0.60    1.407                       1.288--1.536     3989                  4.60    9.9                   9.612--10.269
  Minimal ETE   128                         2.00    5.133                       4.301--6.124     330                   5.20    13.4                  12.046--14.987
  Gross ETE     1476                        13.50   29.735                      28.147--31.412   2297                  21.00   47.0                  44.950--49.052

Confinement:confinement to the thyroid parenchyma; Minimal ETE: minimal extrathyroidal extension;Gross ETE: gross extrathyroidal extension

Clinicopathological parameters that affected CSS and OS {#sec006}
-------------------------------------------------------

The univariate Cox regression analyses revealed that CSS was associated with age, sex, race, histological type, N-stage, M-stage, extension, multifocality, radiation treatment, and surgery type (all P\<0.05, [Table 4](#pone.0218171.t004){ref-type="table"}). Relative to the thyroid confinement group, patients with minimal ETE and gross ETE had significantly poorer CSS and OS in the univariate and multivariate analyses (all P\<0.001, Tables [4](#pone.0218171.t004){ref-type="table"} and [5](#pone.0218171.t005){ref-type="table"}). Race and surgery type were significantly associated with poorer CSS in the univariate analysis but not in the multivariate analysis ([Table 4](#pone.0218171.t004){ref-type="table"}).

10.1371/journal.pone.0218171.t004

###### Clinicopathologic parameters associated with the cancer-specific survival.

![](pone.0218171.t004){#pone.0218171.t004g}

  Parameters                                                  HR                Univariate   HR       Multivariate                                      
  ----------------------------------------------------------- ----------------- ------------ -------- -------------- ------- ------- -------- --------- -------
  Year of diagnosis                                           2004--2008        ref                                          ref                        
  2009--2013                                                  0.801             0.738        0.87     \<0.001        0.843   0.712   0.999    0.049     
  Age at diagnosis                                            \< = 55           ref                                          ref                        
  \>55                                                        10.026            9.023        11.14    \<0.001        5.962   4.949   7.182    \<0.001   
  Sex                                                         Female            ref                                          ref                        
  Male                                                        2.393             2.215        2.586    \<0.001        1.422   1.221   1.657    \<0.001   
  Race                                                        White             ref                                          ref                        0.948
  Black                                                       1.227             1.063        1.417    0.005          0.979   0.699   1.372    0.902     
  Other                                                       1.292             1.151        1.45     \<0.001        1.032   0.833   1.278    0.773     
  Histological Types                                          Papillary         ref                                          ref                        
  Follicular                                                  2.903             2.486        3.39     \<0.001        2.242   1.79    2.808    \<0.001   
  N-Stage                                                     N0                ref                                          ref                        
  N1                                                          4.906             4.503        5.346    \<0.001        2.065   1.734   2.459    \<0.001   
  M-Stage                                                     M0                ref                                          ref                        
  M1                                                          50.921            46.893       55.294   \<0.001        7.593   6.32    9.121    \<0.001   
  Extension                                                   Confinement       ref                                          ref                        
  Minimal ETE                                                 3.285             2.71         3.982    \<0.001        3.709   2.784   4.941    \<0.001   
  Gross ETE                                                   22.077            20.016       24.35    \<0.001        9.318   7.658   11.338   \<0.001   
  Multifocality                                               Yes               ref                                          ref                        
  No                                                          0.665             0.604        0.733    \<0.001        0.743   0.637   0.865    \<0.001   
  Radiation                                                   None or refused   ref                                          ref                        
  Radiation beam or radioactive implants                      14.58             13.353       15.92    \<0.001        3.435   2.725   4.33     \<0.001   
  Radioisotopes or radiation beam plus isotopes or implants   0.442             0.399        0.491    \<0.001        0.804   0.671   0.964    0.018     
  Surgery                                                     Lobectomy         ref                                          ref                        0.143
  Subtotal or near total thyroidectomy                        1.496             1.197        1.869    \<0.001        1.281   0.869   1.889    0.211     
  Total thyroidectomy                                         0.786             0.686        0.901    0.001          0.939   0.722   1.222    0.642     

Confinement:confinement to the thyroid parenchyma; Minimal ETE: minimal extrathyroidal extension;Gross ETE: gross extrathyroidal extension

10.1371/journal.pone.0218171.t005

###### Clinicopathologic parameters associated with the overall survival.
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  Parameters                                                  HR                Univariate   HR       Multivariate                                     
  ----------------------------------------------------------- ----------------- ------------ -------- -------------- ------- ------- ------- --------- -------
  Year of diagnosis                                           2004--2008        ref                                          ref                       
  2009--2013                                                  0.878             0.833        0.926    \<0.001        0.904   0.833   0.98    0.015     
  Age at diagnosis                                            \< = 55           ref                                          ref                       
  \>55                                                        8.176             7.713        8.668    \<0.001        5.933   5.485   6.416   \<0.001   
  Sex                                                         Female            ref                                          ref                       
  Male                                                        2.363             2.256        2.476    \<0.001        1.707   1.594   1.828   \<0.001   
  Race                                                        White             ref                                          ref                       
  Black                                                       1.328             1.223        1.442    \<0.001        1.34    1.185   1.515   \<0.001   
  Other                                                       0.979             0.906        1.058    0.6            0.821   0.73    0.924   0.001     
  Histological Types                                          Papillary         ref                                          ref                       
  Follicular                                                  1.794             1.64         1.961    \<0.001        1.446   1.29    1.621   0.001     
  N-Stage                                                     N0                ref                                          ref                       
  N1                                                          2.05              1.947        2.158    \<0.001        1.416   1.298   1.546   \<0.001   
  M-Stage                                                     M0                ref                                          ref                       
  M1                                                          19.553            18.446       20.725   \<0.001        4.511   3.973   5.121   \<0.001   
  Extension                                                   Confinement       ref                                          ref                       
  Minimal ETE                                                 1.283             1.146        1.437    \<0.001        1.271   1.102   1.466   0.001     
  Gross ETE                                                   5.069             4.812        5.34     \<0.001        2.341   2.142   2.56    \<0.001   
  Multifocality                                               Yes               ref                                          ref                       
  No                                                          0.763             0.723        0.805    \<0.001        0.938   0.875   1.006   0.073     
  Radiation                                                   None or refused   ref                                          ref                       
  Radiation beam or radioactive implants                      5.732             5.367        6.122    \<0.001        1.688   1.458   1.954   \<0.001   
  Radioisotopes or radiation beam plus isotopes or implants   0.458             0.434        0.484    \<0.001        0.656   0.609   0.707   \<0.001   
  Surgery                                                     Lobectomy         ref                                          ref                       0.049
  Subtotal or near total thyroidectomy                        1.092             0.963        1.238    0.172          1.006   0.854   1.184   0.947     
  Total thyroidectomy                                         0.724             0.675        0.777    \<0.001        0.902   0.822   0.99    0.03      

Confinement:confinement to the thyroid parenchyma; Minimal ETE: minimal extrathyroidal extension;Gross ETE: gross extrathyroidal extension

The univariate Cox regression analyses revealed that OS was also associated with age, sex, race, histological type, N-stage, M-stage, multifocality, extension, and radiation treatment (all P\<0.001, [Table 5](#pone.0218171.t005){ref-type="table"}). The univariate and multivariate Cox regression models revealed that poor OS was independently predicted by follicular thyroid carcinoma (univariate hazard ratio \[HR\]: 1.794, 95% CI: 1.640--1.961, P\<0.001; multivariate HR: 1.446, 95% CI: 1.290--1.621, P = 0.001; [Table 5](#pone.0218171.t005){ref-type="table"}). Relative to lobectomy, subtotal or near-total thyroidectomy did not significantly influence OS (univariate HR: 1.092, 95% CI: 0.963--1.238, P = 0.172; multivariate HR: 1.006, 95% CI: 0.854--1.184, P = 0.947; [Table 5](#pone.0218171.t005){ref-type="table"}).

Adjusting for patient features using propensity-score matching {#sec007}
--------------------------------------------------------------

Significant differences in CSS and OS were observed when we compared the groups according to the magnitude of extension (all P\<0.001, [Fig 1A and 1B](#pone.0218171.g001){ref-type="fig"}). Thus, to minimize selection bias, we performed propensity-score matching based on the three sets of covariates. After matching according to age, sex, and race (the first set of covariates), we found that thyroid confinement was associated with better CSS and OS rates than minimal ETE (P\<0.001, Figs [2B](#pone.0218171.g002){ref-type="fig"} and [3B](#pone.0218171.g003){ref-type="fig"}) and gross ETE (P\<0.001, Figs [2A](#pone.0218171.g002){ref-type="fig"} and [3A](#pone.0218171.g003){ref-type="fig"}). After matching according to age, sex, race, TNM stage, and multifocality (the second set of covariates), we found that gross ETE was associated with a lower CSS rate than thyroid confinement (P\<0.001, [Fig 2C](#pone.0218171.g002){ref-type="fig"}) and a similar result was observed for OS (P\<0.001, [Fig 3C](#pone.0218171.g003){ref-type="fig"}). Furthermore, similar results were obtained after matching for the third set of covariates, which included the previous factors plus radiation treatment and surgery type (all P\<0.001, Figs [2E](#pone.0218171.g002){ref-type="fig"} and [3E](#pone.0218171.g003){ref-type="fig"}). Minimal ETE remained associated with a lower OS rate (P = 0.0013, [Fig 3D](#pone.0218171.g003){ref-type="fig"}), although there was no significant difference in the CSS rate between the minimal ETE and thyroid confinement groups (P = 0.666, [Fig 2D](#pone.0218171.g002){ref-type="fig"}). Moreover, after matching for all relevant factors, we failed to detect significant differences between the minimal ETE and thyroid confinement groups in terms of the CSS rate (P = 0.324, [Fig 2F](#pone.0218171.g002){ref-type="fig"}) and the OS rate (P = 0.192, [Fig 3F](#pone.0218171.g003){ref-type="fig"}). The negative results after matching for age, sex, race, TNM stage, and multifocality ([Fig 2D and 2F](#pone.0218171.g002){ref-type="fig"}), and after matching for all relevant factors ([Fig 3F](#pone.0218171.g003){ref-type="fig"}), indicate that these variables account for the decreased CSS and OS associated with minimal ETE.

![Kaplan-Meier curves for cancer-specific survival (A) and overall survival (B) among patients stratified according to subtype.](pone.0218171.g001){#pone.0218171.g001}

![Kaplan-Meier curves for cancer-specific survival in the matched subtype pairs.\
Age, sex, and race matching was performed between the thyroid confinement and gross ETE groups (A) and between the thyroid confinement and minimal ETE groups (B). Age, sex, race, TNM stage, and multifocality matching was performed between the thyroid confinement and gross ETE groups (C) and between the thyroid confinement and minimal ETE groups (D). Age, sex, race, TNM stage, multifocality, surgery, and radiation treatment matching was performed between the thyroid confinement and gross ETE groups (E) and between the thyroid confinement and minimal ETE groups (F).](pone.0218171.g002){#pone.0218171.g002}

![Kaplan-Meier curves for overall survival in the matched subtype pairs.\
Age, sex, and race matching was performed between the thyroid confinement and gross ETE groups (A) and between the thyroid confinement and minimal ETE groups (B). Age, sex, race, TNM stage, and multifocality matching was performed between the thyroid confinement and gross ETE groups (C) and between the thyroid confinement and minimal ETE groups (D). Age, sex, race, TNM stage, multifocality, surgery, and radiation treatment matching was performed between the thyroid confinement and gross ETE groups (E) and between the thyroid confinement and minimal ETE groups (F).](pone.0218171.g003){#pone.0218171.g003}

Discussion {#sec008}
==========

Cases with ETE can be classified as minimal ETE (i.e., extension to the thyroid capsule, sternothyroid muscle, or perithyroidal soft tissue) or gross ETE (i.e., extension to the subcutaneous soft tissue, larynx, esophagus, trachea, recurrent laryngeal nerve, prevertebral fascia, mediastinal vessels, or carotid arteries) \[[@pone.0218171.ref014]\]. The magnitude of ETE has historically been thought to influence the assignment of T status, which in turn influences the TNM stage and selection of treatment options. However, it is difficult to define the precise boundary of extrathyroid and intrathyroidal tissues when determining the extent of cancer invasion, as both living patients and autopsy cases have failed to exhibit a complete or continuous fibrous capsule around the thyroid gland. This is a source of concern at our institution, as patients with AJCC stage III and stage IV tumors are routinely treated using RAI remnant ablation, or using external beam radiation therapy if they are older and have RAI-resistant tumors \[[@pone.0218171.ref015], [@pone.0218171.ref016]\]. Thus, there is debate regarding the importance of ETE in predicting the progression of differentiated thyroid carcinoma.

Recent research has indicated that ETE exerts only a minor effect on the rate of recurrence-free survival and related disease management decisions \[[@pone.0218171.ref008]--[@pone.0218171.ref010], [@pone.0218171.ref017]\]. Thus, minimal ETE was removed from the eighth edition of the AJCC system, with a greater emphasis placed on gross ETE. However, the present study's univariate and multivariate analyses revealed that patients with minimal ETE had significantly lower rates of CSS and OS than patients with thyroid confinement. Moreover, patients with gross ETE had poorer rates of CSS and OS than patients with minimal ETE. However, the influence of minimal ETE on prognosis appears to be accounted for by other known variables including age, sex, race, TNM stage, and multifocality. Whether minimal ETE should be omitted from the AJCC system, as is the case in the eighth edition, deserves further study.

Woo et al. have reported that the presence or absence of minimal ETE did not significantly influence recurrence-free survival among patients with solitary papillary thyroid carcinoma or microcarcinoma \[[@pone.0218171.ref017]\]. However, that study had a small sample size and did not consider follicular thyroid cancer. More importantly, that study also failed to incorporate propensity-score matching in order to minimize the effect of potentially confounding factors. In contrast, the SEER database includes patient data from diverse geographical regions and is considered the gold-standard database for tumor surveillance and related analysis in the US, as it contains data from approximately 10% of the American patient population \[[@pone.0218171.ref018]\]. Therefore, the present study provides greater clarity regarding the prognostic implications of the magnitude of ETE among patients with differentiated thyroid cancer.

Several cohort studies have indicated that using a diagnostic age of 55 years as the prognostic cut-off provided better discrimination than using a cut-off of 45 years. Thus, patients are now classified into low- and high-risk groups based on ages of ≤55 years and \>55 years \[[@pone.0218171.ref011]\]. The present study also used this cut-off value for the univariate and multivariate Cox regression analyses, and the results confirmed that an older age at diagnosis was associated with poorer CSS and OS rates.

Most studies have agreed that RAI ablation is effective for improving outcomes among patients with ETE to the sternothyroid muscle (i.e., minimal ETE), although few reports have examined the prognostic significance of ETE to the thyroid capsule \[[@pone.0218171.ref019]--[@pone.0218171.ref021]\]. Based on the outcomes of our study, we suggest that minimal ETE is associated with poorer CSS and OS outcomes. Thus, omitting minimal ETE from the definition of T3 disease would likely result in these patients being less likely to undergo RAI ablation, which appears problematic. Therefore, additional research is needed to refine the classification of ETE, to better understand the effects of minimal ETE, and to improve the personalized treatment of thyroid cancer.

The present study has several limitations. First, the SEER database lacks accurate information regarding the precise magnitude of ETE, and we could not perform specific analyses of the ETE subgroups. Second, we did not account for biochemical and genetic factors, recurrence, or surgery-related comorbidities in our analyses. Third, the SEER database does not include information regarding whether the patients underwent repeated surgery as well as detailed information concerning the radioactive iodine (RAI) therapy, and this lack of information may have biased our findings. Fourth, the propensity-score matching protocol and caliper size might have influenced the outcomes, and it is unclear whether the goodness-of-fit of the propensity score estimation model was sufficient.

Conclusion {#sec009}
==========

In conclusion, we suggest that minimal ETE may be associated with an increased risk of poor CSS and OS outcomes. In addition, patients with gross ETE have a greater risk of poor outcomes than patients with minimal ETE or thyroid confinement. Therefore, we believe that further discussion and research are needed to examine the omission of minimal ETE from the current AJCC staging system.
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